Impax Settles Solodyn Case: Jury Dismissed in Trial

Impax Laboratories Inc. agreed to pay $20 million to settle claims that it conspired with Medicis Pharmaceutical Corp. to monopolize the generic market for Medicis’ acne drug, Solodyn.

The settlement with end-payor plaintiffs comes after 10 days of bench trial before Judge Denise J. Casper in the U.S. District Court for the District of Massachusetts. She discharged the jury March 29 when the parties filed their settlement. End-payors include health plans and benefit plans that paid the price of members Solodyn prescriptions.

A jury decision in the case would have been important because claims of this type, alleging that drug ...